相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas
Marco Losa et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Temozolomide for aggressive ACTH pituitary tumors: failure of a second course of treatment
Mariana Campdera et al.
PITUITARY (2016)
Atypical pituitary adenomas: 10 years of experience in a reference centre in Portugal
F. Tortosa et al.
NEUROLOGIA (2016)
Therapeutic innovations in endocrine diseases - part 3: temozolomide and future therapeutics for aggressive pituitary tumors and carcinomas
Helene Lasolle et al.
PRESSE MEDICALE (2016)
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide
Daniel Bengtsson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center
Filippo Ceccato et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Temozolomide Therapy for Aggressive Pituitary Tumors: Results in a Small Series of Patients from Argentina
Oscar D. Bruno et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2015)
A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up
Jacqueline Trouillas et al.
ACTA NEUROPATHOLOGICA (2013)
Aggressive Silent GH Pituitary Tumor Resistant to Multiple Treatments, Including Temozolomide
Marie Batisse et al.
CANCER INVESTIGATION (2013)
Temozolomide and unusual indications: Review of literature
Zuzana Tatar et al.
CANCER TREATMENT REVIEWS (2013)
DNA Mismatch Repair Protein (MSH6) Correlated With the Responses of Atypical Pituitary Adenomas and Pituitary Carcinomas to Temozolomide: The National Cooperative Study by the Japan Society for Hypothalamic and Pituitary Tumors
Toshio Hirohata et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Aggressive and malignant prolactin pituitary tumors: pathological diagnosis and patient management
Ilyess Zemmoura et al.
PITUITARY (2013)
Long-term control of a MEN1 prolactin secreting pituitary carcinoma after temozolomide treatment
Melanie Philippon et al.
ANNALES D ENDOCRINOLOGIE (2012)
Temozolomide in the management of dopamine agonist-resistant prolactinomas
B. C. Whitelaw et al.
CLINICAL ENDOCRINOLOGY (2012)
Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment
Gerald Raverot et al.
CLINICAL ENDOCRINOLOGY (2012)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 20052009
Therese A. Dolecek et al.
NEURO-ONCOLOGY (2012)
New targeted therapies in pituitary carcinoma resistant to temozolomide
Emmanuel Jouanneau et al.
PITUITARY (2012)
Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis
Ferdinand Roelfsema et al.
PITUITARY (2012)
Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases
Marco Losa et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression
Zachary M. Bush et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Temozolomide Treatment in Aggressive Pituitary Tumors and Pituitary Carcinomas: A French Multicenter Experience
Gerald Raverot et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
THE CORRELATION AND PROGNOSTIC SIGNIFICANCE OF MGMT PROMOTER METHYLATION AND MGMT PROTEIN IN GLIOBLASTOMAS
Van Thang Cao et al.
NEUROSURGERY (2009)
Antitumour effects of temozolomide in a man with a large, invasive prolactin-producing pituitary neoplasm
Luis V. Syro et al.
CLINICAL ENDOCRINOLOGY (2006)
Long-term response of pituitary carcinoma to temozolomide - Report of two cases
Camilo E. Fadul et al.
JOURNAL OF NEUROSURGERY (2006)
Clinical review: Diagnosis and management of pituitary carcinomas
GA Kaltsas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
